The impact of Medicare prescription drug coverage on the use of antidementia drugs

BACKGROUND: Cholinesterase inhibitors and memantine are prescribed to slow the progression dementia. Although the efficacy of these drugs has been demonstrated, their effectiveness, from the perspective of patients and caregivers, has been questioned. Little is known about whether the demand for cho...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowler, Nicole R, Chen, Yi-Fan, Thurton, Christiana A, Men, Aiju, Rodriguez, Eric G, Donohue, Julie M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651712/
https://www.ncbi.nlm.nih.gov/pubmed/23621892
http://dx.doi.org/10.1186/1471-2318-13-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651712/
https://www.ncbi.nlm.nih.gov/pubmed/23621892
http://dx.doi.org/10.1186/1471-2318-13-37

Ejemplares similares